Salt and crystalline forms thereof of a drug

Assignee: Abbott Laboratories

View Patent ↗

Loading inventors, assignments & file history…

Monitor This Case

Get email alerts when status or documents change.

Order Certified Copies

Most orders are placed with the USPTO same day — all within 24 business hours.

Order via The Patent Place →

Pre-filled with this patent's details

Quick Facts

Patent No.: US 8,273,892
App. No.: 12/763,476
Granted: Sep 25, 2012
Kind: B2

External Links

USPTO Patent Center↗ Full Patent PDF↗

Abstract

A crystalline form of a drug, ways to make it, compositions containing it and methods of treatment of diseases and inhibition of adverse physiological events using it are disclosed.

Claims (1)

1. D-Glucitol, 1-deoxy-1-(methylamino)-, 1-(6-amino-3,5-difluoropyridin-2-yl)-8-chloro-6-fluoro-1,4-dihydro-7-(3-hydroxyazetidin-1-yl)-4-oxo-3-quinolinecarboxylate (salt).

Assignments (4)

RELEASE OF SECURITY INTEREST Recorded Jan 5, 2018

From: SUCHARD SA LLC

To: MELINTA SUBSIDIARY CORP. (F/K/A MELINTA THERAPEUTICS, INC.)

Reel/Frame 044547/0939 →

SECURITY INTEREST Recorded Jun 28, 2017

From: MELINTA THERAPEUTICS, INC.

To: SUCHARD SA LLC

Reel/Frame 042854/0753 →

ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Apr 10, 2013

From: ABBOTT LABORATORIES

To: ABBVIE INC.